AstraZeneca said it was aware of the investigation by the Korea Disease Control and Prevention Agency (KDCA), but the safety of the vaccine has been extensively studied in clinical trials with data confirming it is generally well tolerated.
“KDCA is conducting epidemiological surveys with relevant local authorities...to confirm any link with inoculation,” KDCA Director Jeong Eun-kyeong told a briefing.
A 63-year-old nursing home patient with cerebrovascular disease, developed symptoms including high fever, after being given the vaccine four days ago. The man was moved to a larger hospital on Tuesday, but died after showing symptoms of blood poisoning and pneumonia.
Another nursing home patient in his 50s with a cardiac disorder and diabetes died on Wednesday after suffering multiple heart attacks, having received the vaccine a day earlier.
The KDCA said that out of the people who had received the coronavirus vaccines, 207 had adverse reactions, including three cases of severe allergic reactions, known as anaphylaxis.
As we reported earlier, Health Minister of Ukraine Maksym Stepanov stated that it is planned to provide the access to the vaccines from coronavirus to everyone wishing until the end of 2021.
Stepanov noted that 6,800 people are vaccinated in Ukraine as of now. However, until the end of the week, it is planned to reach the rate of 10,000 vaccinated people per day.
“Our strategy – until the end of 2021, to provide the access to the vaccine for everyone wishing. Free of charge,” the minister added.